Elite Pharmaceuticals Inc (ELTP)

[PH4RM4C3UT1C4LS]

I do understand what you are saying, but what options are you thinking? I cannot seem to find any negative scenarios, that would fit the bill, so to speak.

To my knowledge there are only a few things that make sense. Conversion for a buyout, as you would need the shares to be converted to common to get the true valuation and dividends per each share. Conversion for a partnership, for the same reasons as above. Then, thirdly, the conversion to fund the trials needed to respond to the CRL. I do not think the third is a viable option though, as 24 million dollars, far exceeds the small 5 million study that a new BE trial would necessitate. Leaves me with the first two to ponder, but with who?